Claims for Patent: 10,512,640

Summary for Patent: 10,512,640

Title:	Compositions and methods for treating diseases of the nail
Abstract:	Methods and compositions for treating disorders of the nail and nail bed. Such compositions contain a vehicle in which all components of the composition are dissolved, suspended, dispersed, or emulsified, a non-volatile solvent, a wetting agent, and a pharmaceutically active ingredient that is soluble in the non-volatile solvent and/or a mixture of the vehicle and the non-volatile solvent, and which composition is effective in treating a disorder of the nail or nail bed.
Inventor(s):	Winckle; Gareth (Biot, FR), Fieldson; Gregory T. (Morgantown, WV)
Assignee:	Dow Pharmaceutical Sciences, Inc. (Petaluma, CA)
Application Number:	15/849,414
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 10,512,640
Patent Claims:	1. A method for the treatment of onychomycosis comprising topically applying to the surface of the nail of an individual suffering from onychomycosis a pharmaceutical composition comprising ethanol, diisopropyl adipate, C12-15 alkyl lactate, cyclomethicone, and a triazole antifungal agent; wherein the composition is formulated as a solution; wherein the ethanol is present in the composition at a concentration of at least 50% w/w; wherein the cyclomethicone is present in the composition at a concentration between 10% and 15% w/w; wherein the diisopropyl adipate is present in the composition at a concentration between 8% and 15% w/w; wherein the C12-15 alkyl lactate is present in the composition at a concentration between 8% and 15% w/w; wherein the composition does not comprise a polymeric film forming compound; and wherein the application of the composition is in an amount and for a time sufficient to ameliorate the symptoms of the onychomycosis. 2. The method of claim 1, wherein the triazole antifungal agent is (2R,3R)-2-(2,4-difluorophenyl)-3-(4-methylenepiperidine-1-yl)-1-(1H-1,2,4- -triazole-1-yl)butane-2-ol. 3. The method of claim 1, wherein the concentration of the triazole antifungal agent is between 2% and 15%. 4. The method of claim 1, wherein the concentration of ethanol is at least 80% w/w. 5. The method of claim 1, wherein the pharmaceutical composition is applied once daily.